The Global DiGeorge Syndrome Drug Market Size is Expected to Grow from USD 365.38 Million in 2024 to USD 723.90 Million by 2035, at a CAGR of 6.41% during the forecast period 2025 To 2035.DiGeorge syndrome is a rare genetic disorder caused by a deletion on chromosome 22 (22q11.2). It affects multiple body systems, leading to heart defects, immune deficiencies, low calcium levels, and developmental delays.